<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Crohn’s disease":1,
"Korea":1,
"Ulcerative colitis":1,
"cancer":4,
"population-based":1,
"Endocrine surgery":2,
"general surgery":1,
"multidisciplinary":1,
"online referrals":1,
"otolaryngology":1,
"self-referred":1,
"Calcificaciones":1,
"Calcifications":1,
"Carcinoma tiroideo":1,
"Doppler":2,
"Ecografía":1,
"Elastografía":1,
"Elastography":2,
"Malignancy":3,
"Malignidad":1,
"Nódulo tiroideo":2,
"Thyroid carcinoma":4,
"Thyroid nodule":9,
"Ultrasound":5,
"Thyroid":6,
"core needle biopsy":1,
"fine needle aspiration":1,
"thyroid cancer":31,
"thyroid malignancy":1,
"De novo cancer":1,
"Head and neck malignancy":1,
"Immunosuppression":1,
"Organ recipients":1,
"Organ transplantation":1,
"Prognosis":8,
"Solid organ transplantation":1,
"Squamous cell carcinoma":2,
"Iodine":1,
"Microcarcinoma":2,
"Papillary thyroid cancer":7,
"Risk factors":4,
"Thyroid thyroglobulin antibody":1,
"Thyroid-stimulating hormone":1,
"Thyroid nodules":5,
"agreement":1,
"diagnosis":4,
"guideline":1,
"ultrasonography":5,
"ETV6":1,
"fluorescent in situ hybridization":1,
"immunohistochemistry":4,
"mammary analogue secretory carcinoma":1,
"Anti-tumor":1,
"Head and neck squamous cell carcinoma":1,
"MicroRNA":2,
"SPOCK1":1,
"miR-150-3p":1,
"miR-150-5p":1,
"anti-glutamate receptor antibody":1,
"limbic encephalitis":1,
"paraneoplastic syndrome":1,
"thymoma":1,
"Microwave ablation":3,
"Radiofrequency ablation":2,
"Checkpoint inhibitors":1,
"Immunostimulation":1,
"Monoclonal antibodies":1,
"PD-1 blockade":1,
"Side effects":1,
"Expanding indications":1,
"Robotic thyroidectomy":1,
"Surgical completeness":1,
"Surgical safety":1,
"hyperthyroidism":3,
"nodule volume":1,
"thyroid function":2,
"Benign thyroid nodule":2,
"stress":1,
"Percutaneous laser ablation":1,
"toxic nodules":1,
"Lung adenocarcinoma":2,
"Lung squamous cell carcinoma":1,
"Next-generation sequencing":1,
"TTF-1":1,
"p40":1,
"guidelines":1,
"overdiagnosis":2,
"radioiodine":2,
"Breast cancer":11,
"Chemotherapy":2,
"Cortisol":1,
"Fatigue":1,
"Levothyroxine":2,
"high-intensity focused ultrasound (HIFU)":1,
"thermal ablation":1,
"Diagnostic":1,
"Hypophysite":1,
"Hypophysitis":1,
"Immunotherapy":2,
"Immunothérapie":1,
"Traitement":1,
"Treatment":2,
"Benign metastasizing leiomyoma":1,
"Driver gene":1,
"Targeted deep sequencing":1,
"Uterine leiomyoma":1,
"cohort studies":1,
"head and neck cancer":2,
"pesticides":1,
"review":1,
"Pediatric thyroid cancer survivors":1,
"SEER":2,
"Second malignancy":1,
"Crete":1,
"Gamma-ray":1,
"Papillary thyroid carcinoma":18,
"calcitonin":1,
"fine-needle aspiration cytology":1,
"medullary thyroid carcinoma":4,
"mixed medullary-follicular carcinoma":1,
"adolescents":1,
"young adults":1,
"classification":1,
"defect":1,
"palatomaxillary":1,
"prosthodontic":1,
"reconstruction":1,
"Ablation techniques":1,
"High-intensity focused ultrasound ablation":1,
"Interventional ultrasonography":1,
"Nodular goitre":1,
"Ultrasound imaging":1,
"epidemiology":2,
"melanoma":2,
"population surveillance":1,
"BRAF":2,
"circulating tumor DNA":1,
"digital polymerase chain reaction (PCR)":1,
"papillary thyroid carcinoma (PTC)":2,
"IVLBCL":1,
"diagnostic pitfall":1,
"intravascular large B-cell lymphoma":2,
"thyroid lymphoma":1,
"BRAF mutation":1,
"The Cancer Genome Atlas (TCGA)":1,
"molecular subtypes":1,
"prediction":2,
"thyroid surgery":4,
"HER2":1,
"Ki-67":2,
"MIB-1":1,
"Membranous staining":1,
"IDH2":1,
"sanger sequencing":1,
"CO2 insufflation":2,
"cosmetic effect":1,
"suspension system":1,
"transoral endoscopic thyroid surgery":1,
"tri-vestibular approach":1,
"fine-needle aspiration (FNA) biopsy":1,
"imaging features":1,
"well differentiated thyroid carcinoma":1,
"molecular marker tests":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":2,
"Papillary thyroid microcarcinoma":3,
"complications":1,
"microwaves":1,
"risk":1,
"thyroid gland":3,
"radioactive iodine therapy":3,
"thyroid lobectomy":1,
"adolescence":1,
"childhood":1,
"recurrence":4,
"Lymph node metastasis":3,
"Microcalcification":1,
"TI-RADS":2,
"localization":1,
"radioactive":1,
"seed":1,
"Atovaquone":1,
"Doxorubicin":1,
"Mitochondrial respiration":1,
"STAT3":1,
"craniospinal irradiation":1,
"medulloblastoma":1,
"photon radiation":1,
"second neoplasms":1,
"cabozantinib":1,
"pediatrics":1,
"phase 1":1,
"common 2D endoscopic technique":1,
"three-dimensional endoscopic technique":1,
"thyroidectomy":4,
"Chlordane":1,
"DDT":1,
"Organochlorines":1,
"Polychlorinated biphenyls":1,
"children":1,
"head and neck":1,
"malignancies":1,
"neoplasms":1,
"Exosomes":1,
"Osteoclastogenesis":1,
"Pdcd4":1,
"miR-21":1,
"Thyroid Imaging, Reporting, and Data System (TI-RADS)":1,
"subcentimeter thyroid nodules":1,
"MEN2":1,
"RET":1,
"kinase inhibitors":2,
"oncogene":1,
"differentiated thyroid carcinoma":2,
"follicular thyroid carcinoma":1,
"radioiodine therapy":1,
"LRRC8D mutation":1,
"NDRG1 mutation":1,
"The Cancer Genome Atlas":1,
"Whole-exome sequencing":1,
"Meta-analysis":1,
"OSNA":1,
"Sensitivity":1,
"Specificity":1,
"Benign thyroid disorders":1,
"Population model":1,
"Radioiodine uptake":1,
"Variability":1,
"Benign thyroid disease":1,
"Mixed follicular-papillary variant":1,
"Multifocality":2,
"Thyroid weight":1,
"Tumour size":1,
"Metabolism":4,
"Pyruvate kinase M2":1,
"Afirma":1,
"Afirma test":1,
"Bethesda III":1,
"Bethesda IV":1,
"Citología indeterminada":1,
"Diagnóstico molecular":1,
"Indeterminate cytology":1,
"Molecular diagnosis":1,
"Thyroseq":1,
"Thyroseq test":1,
"AZD2014":1,
"Anaplastic thyroid carcinoma":1,
"Chemo-resistance":1,
"Paclitaxel":1,
"Targeted therapy":1,
"mTOR":1,
"Endoscopic thyroidectomy":1,
"anterior neck surgery":1,
"breast approach":1,
"cosmesis":1,
"elastic traction":1,
"Cell cycle":2,
"Estrogen receptor":1,
"Long non-coding RNA":1,
"MIAT":1,
"Proliferation":5,
"FOXO1":1,
"GAS5":1,
"Metastasis":4,
"Progression":1,
"TNBC":1,
"miR-196a-5p":1,
"Cytology":1,
"Follicular thyroid tumors":1,
"Chemoresistance":1,
"Glucose":1,
"Microenvironment":1,
"PKM2":1,
"NEMO gene":1,
"X-linked recessive Mendelian susceptibility to mycobacterial diseases":1,
"mutation":2,
"nuclear factor-κB":1,
"Neoplasm":1,
"Shear wave":1,
"Clinical competence":1,
"Risk assessment":1,
"Thyroid diseases":1,
"Dual-luciferase reporter gene assay":1,
"Insulin like growth factor 1 receptor":1,
"Invasion":3,
"Long noncoding RNA PVT1":1,
"Migration":2,
"RNA-pull down":1,
"ceRNA":1,
"microRNA-30a":1,
"EORTC QLQ-C30":1,
"SF-36":1,
"health-related quality of life":1,
"life style behavior":1,
"thyroid cancer survivors":1,
"lobectomy":1,
"low risk":1,
"thyroglobulin":2,
"thyroid cytology":1,
"thyroid ultrasound":1,
"TNM staging":1,
"follicular thyroid cancer":2,
"survival":2,
"thyroid neoplasms":6,
"Incidence":2,
"Period and population analysis":1,
"Trends in thyroid cancer":1,
"TSH":1,
"Apoptosis":3,
"Colon cancer":3,
"Dioscorea bulbifera":1,
"ERK1/2 and JNK":1,
"Antioxidant":1,
"Differentiated thyroid cancer":2,
"Radiation mitigators":1,
"Radioiodine treatment":1,
"Radioprotector":1,
"Vitamin C":1,
"Intra-operative neural monitoring":1,
"Lymphadenectomy":1,
"Mesoesophagus":1,
"Prone esophagectomy":1,
"Recurrent laryngeal nerve":2,
"2D-DIGE":1,
"Honokiol":1,
"MALDI-TOF":1,
"Proteomics":1,
"radiomics":1,
"pediatric renal tumor":1,
"renal cell carcinoma":1,
"transcription factor E3 (TFE3) gene":1,
"transcription factor EB (TFEB) gene":1,
"translocation renal cell carcinoma":1,
"Robotic transaxillary approach":1,
"Robotic transaxillary surgery":1,
"Surgical treatment of thyroid cancer":1,
"Thyroid cancer outcomes":1,
"Well-differentiated thyroid cancer":1,
"autophagy":1,
"flavokawain B":1,
"Atypia":1,
"Fluoro-deoxy-glucose uptake (FDG uptake)":1,
"Follicular neoplasm":1,
"Positron emission tomography/computed tomography (PET/CT)":1,
"FSH":1,
"inhibin B":1,
"sperm aneuploidy":1,
"testicular function":1,
"Hashimoto's thyroiditis":1,
"Histogenesis":1,
"Radiotherapy":3,
"Surgery":2,
"Thyroid squamous cell carcinoma":1,
"Central lymph node dissection":1,
"Permanent hypoparathyroidism":1,
"Recurrent laryngeal nerve injury":1,
"Reoperative central lymph node dissection":1,
"Thyroid cancer recurrence":1,
"age":1,
"papillary carcinoma":1,
"thyroid neoplasm":2,
"tumor size":1,
"LINC00704":1,
"biomarker":3,
"lncRNAs":1,
"profiling":1,
"chemotherapy-only conditioning":1,
"hematopoietic stem cell transplantation":1,
"pediatric recipients":1,
"thyroid disorders":2,
"Cancer methylation":1,
"Global DNA methylation":1,
"radioactive iodine":1,
"Glutaminase":1,
"Glutamine":1,
"Glutaminolysis":1,
"CD56":1,
"PCR":1,
"SLP-2":1,
"TROP-2":2,
"TCGA data":1,
"early cancer":1,
"gene expression":1,
"pattern recognition":1,
"screening method":1,
"signature genes":1,
"Case–control study":1,
"Odd ratio":1,
"Thyroid disease":5,
"Akt/GSK3β/β-catenin signaling pathway":1,
"IQ motif and ubiquitin domain containing":1,
"cell migration":1,
"cell proliferation":1,
"adenocarcinoma":1,
"carcinoma":1,
"cell nucleus":1,
"follicular":1,
"histology":1,
"papillary":1,
"SLC5A5":1,
"fluorodeoxyglucose":1,
"positron emission tomograph":1,
"Li-Fraumeni syndrome":1,
"MEN1":1,
"endocrine tumour syndromes":1,
"genetics":1,
"Mouse models":1,
"Oncogenes":1,
"Oncology":3,
"P53":1,
"osteosarcoma":1,
"period analysis":1,
"relative survival":1,
"sex":1,
"socioeconomic status":1,
"B-cell receptors":1,
"T-cell receptors":1,
"complementarity-determining region 3":1,
"high-throughput sequencing":1,
"BRAF V600E":2,
"Colorectal carcinoma":1,
"VE1":1,
"Contrast-enhanced ultrasound":1,
"Time-intensity curve":1,
"131-iodine whole-body scan":1,
"Nephrectomy":1,
"Renal tumour":1,
"Thyroid ectopia":1,
"BRAF-activated long noncoding RNA":1,
"cyclin D1":1,
"long noncoding RNA":1,
"thyroid stimulating hormone receptor":1,
"HOX transcript antisense intergenic RNA":1,
"Knowledge Explorer":1,
"Reactome":1,
"SPARQL reasoning":1,
"mass spectrometry":1,
"pathway analysis":1,
"random positioning machine":1,
"semantic network":1,
"Cone-beam computed tomography (CBCT)":1,
"Monte Carlo simulation":1,
"Organ doses":1,
"PCXMC":1,
"Risk of exposure-induced death (REID)":1,
"Child":1,
"Follow-up studies":1,
"Endoscopy":1,
"EudraVigilance":1,
"Lithium":1,
"Renal cancer":1,
"VigiAccess":1,
"Fallopian tubal cancer":1,
"Ovarian cancer":1,
"Primary peritoneal cancer":1,
"Second primary":1,
"ATC":1,
"Biomarkers":1,
"FTC":1,
"Molecular markers":2,
"NGS":1,
"PTC":1,
"Obesity":1,
"Thyroid hormones":1,
"Thyroxine":1,
"Triiodothyronine":1,
"endocrine cancer":2,
"urological cancer":1,
"GO–HAp":1,
"HSV-TK":1,
"gene therapy":1,
"nanoparticles":1,
"Imatinib mesylate":1,
"Rectal GIST":1,
"TAMIS":1,
"Hospital volume":1,
"Neck dissection":2,
"Overall survival":2,
"Recombinant human thyrotropin":1,
"Therapeutic response":1,
"18F":1,
"18F-NaF":1,
"68Ga":1,
"Gallium-68":1,
"PET/CT":1,
"carcinogens":1,
"eating habits":1,
"environment":1,
"iodine intake":1,
"volcanoes":1,
"xenobiotics":1,
"Hürthle cell":1,
"chromosomal losses":1,
"complex I":1,
"haploid":1,
"loss of heterozygosity":1,
"mitochondria":1,
"mtDNA":1,
"oncocytic":1,
"Hurthle cell carcinoma":1,
"copy-number alterations":1,
"fusion genes":1,
"genomics":1,
"mitochondrial mutations":1,
"transcriptome":1,
"Medullary":1,
"Multiple endocrine neoplasia":1,
"Pituitary adenoma":1,
"Pituitary neoplasms":1,
"Adrenocortical adenoma":1,
"Case Report":1,
"Hereditary Tumor Syndrome":1,
"Malignant Peritoneal Mesothelioma":1,
"PTEN-Hamartoma-Tumor-Syndrome":1,
"Verrucous Carcinoma":1,
"lymph node posterior to right recurrent laryngeal nerve":1,
"model":1,
"BRAFV600E":2,
"Biological marker":1,
"Microarray":1,
"Extrathyroidal extension":2,
"Lymphovascular invasion":1,
"YAP1":1,
"miR-497":1,
"thyroid papillary carcinoma":2,
"Endocrinology":1,
"Transcription":1,
"Clinical features":1,
"Malignant tumors":1,
"Neuromyelitis optica spectrum disorders":1,
"Influencing factors":1,
"Iodine radioisotopes":1,
"Treatment outcome":1,
"cytotoxicity":1,
"differentiation":1,
"immune escape":1,
"natural killer cell":1,
"prostaglandin E2":1,
"endocrine":1,
"follicular adenoma":1,
"follicular carcinoma":1,
"organ system pathology":1,
"pathology competencies":1,
"AP-2α":1,
"notch signaling":1,
"heme oxygenase":1,
"reactive oxygen species":1,
"endocrine disruptors":1,
"flame retardants":1,
"polybrominated diphenyl ethers":1,
"brainstem / cerebellum":1,
"cancer - see oncology":1,
"immunology":1,
"Taiwan":1,
"bladder cancer":1,
"prostate cancer":1,
"vitiligo":1,
"cytopathology":1,
"molecular testing":1,
"personalized medicine":1,
"thyroid Bethesda system":1,
"thyroid FNA":1,
"thyroid indeterminate lesions":1,
"Circular RNA":1,
"miRNA":1,
"nuclear medicine":1,
"XIST":1,
"miR-141":1,
"Borderline tumor":1,
"non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"precursor tumor":1,
"uncertain malignant potential (UMP)":1,
"robotic surgery":1,
"Transoral thyroidectomy":1,
"completion thyroidectomy":1,
"remote-access thyroidectomy":1,
"carcinoma of thyroid":1,
"hot nodule":1,
"CXC chemokine receptor":1,
"squamous cell carcinoma of head and neck":1,
"stromal cell-derived factor-1":1,
"loss of signal":1,
"nerve injury":1,
"staged thyroidectomy":1,
"endocrine malignancy":1,
"systemic inflammation response index (SIRI)":1,
"cancer-specific survival":1,
"propensity score matching":1,
"Bilaterality":1,
"Surgical margin":1,
"whole-exome-sequencing":1,
"CEACAM1":1,
"Cowden syndrome":1,
"MALT lymphoma":1,
"MIB2":1,
"PTEN":1,
"renal carcinoma":1,
"BRAF inhibitors":1,
"anaplastic thyroid cancer":1,
"medullary thyroid cancer":1,
"Screening":1,
"Carcinoma, hepatocellular":1,
"Cirrhosis":1,
"Hepatitis B virus":1,
"Liver failure":1,
"Sarcomatoid carcinoma of pancreas (SCP)":1,
"spindle cell":1,
"undifferentiated pleomorphic sarcoma of the pancreas (UP-PS)":1,
"BRAF(V600E) mutation":1,
"Fine needle aspiration biopsy (FNAB)":1,
"Papillary thyroid cancer (PTC)":1,
"TMPRSS4":1,
"fine needle aspiration biopsy":1,
"fine needle aspiration cytology":1,
"throidectomy":1,
"autopsy":1,
"neoplastic PD-L1 expression divergence or heterogeneity":1,
"classification and regression trees":1,
"liquid based cytology":1,
"machine learning":1,
"morphology":1,
"thyroid cytopathology":1,
"Cohort study":1,
"Treatment strategy":1,
"metastatic renal cell carcinoma":1,
"orbital mass":1,
"orbital metastasis":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2018年8月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAO4AAADICAYAAADvG90JAAAWNElEQVR4Xu2dedS/5ZzHX/6YmVJRKi1ojwqjydaqIilJacgkhFSYM5UkSyiFSpaypIXRiJBjyJqTZBjLjL2hxZpMRqEkSxznzJz3dH1PT0/P83zv5bqv5b7fn3O+5+l3uu/r8/m8r/t9L9f1We6GxQgYgeoQuFt1FttgI2AEMHF9ERiBChEwcSucNJtsBExcXwNGoEIETNwKJ80mGwET19dAbAS2BDYNv/sA9wLWAtYEVpuj7M/Ab8LvZuB64Mrw+3lsQ2sez8Stefby2r4TsBtw/wVEve+AJv0C+BxwOfAZ4GcD6ip+aBO3+CkqxsB1gKcBewK7Aqtntuwa4JPA24CfZLYluXoTNznkVSlcA/h74OnAYwq2/ELgNcBVBdsY1TQTNyqcoxnsAcAxgbB3r8grvUafCVxckc2dTDVxO8E22pM2CRf+Eyv38EvAUcA3KvdjWfNN3LHObHu/TgJe2f60os/Q6/PYfPp/wE3coq+7JMZtD7wf0NN2jPKFsKimraXSZGNgL+BfgNvaGGfitkFrfMe+FDhlfG7dxaNbgBcAWsTKLdrXfirwDGAH4BHA19oaZeK2RWwcx2vB6WOFrxQPgfR5wOFDDDxnTAWePBn4h/CEnR1+EPCBLvYMQdytp7Qs3wX0As5RIMPuBdiRw4QvA/uE6Kyh9e8NHBy21FZZpExrCid0NWAI4upOrjvM/sCtXQ3zeYMhoK2S2leN+4KjMMpdgJv6DrTE+YooU6CKnqYK9VxKPgQc2Ed3bOJuGOJLZdN3wmuBQtUsZSBwLnBYGaZkt+KK8NYRg7wK+3xm+G7daI5nXwce3tf72MQ9GnjzAqO0krcHcHVfQ31+bwQOAD7ce5RxDaCHi67PX3Vwa/0QoKJX4W0bnq/46ocCv2x4/LKHxSbuUt9OyvJ4PPDVvsb6/M4IKPj/v0KGTudBRnqiyKstsSbbMfcMC0xaFW67RqDxHwnoSd9bYhJ3XeDGZSz6Y3BY37+W9AhcBjw6vdpqNCrS6uSQdbSU0SLpc8O3a1en9gU+0fXkxefFJO6hwDvnGPY84JxYxnucRggcApzf6EgfpLfD2RPxr4ENIgWmHAu8MSa8MYnbdLXydcDxMZ3wWMsisCrwY0DfY5Y8CLwbeE5s1TGJ+78tjNNyuFbhmnxXtBjWhy5C4MQ+e4VGszcCegXfufcoSwwQi7jK1fxsSwMV5qX3/htanufDmyGwXkgw11PXkh4BJfdrBVmv39ElFnFPB/Qe31ZUR+hxwHfbnujj5yLwcuC1c4/yAUMg8NuwV/v9IQbXmLGIq62GB3U08vdhtc4rzh0BXOY0VYPYKu6QHq0hAtob1kr+YBKDuMp2+HUEC18GnBphHA9x+yuaInQs6RFQZNq83ZXeVsUgruJeY5UK6R3D2RuRcQxwRqgAMQ5v6vFCuL8whbkxiHsacFxEYxVhtd8KwRwRVY12KMWHa3HKkg6BSwBlAyWRGMRVhQFlWsQUXXgi73/GHHQiYz3Qi33JZ1rZRgpn/F0qzTGIq8WloSoBvgh4UyowRqLn+cBZI/GlBjeUoPAw4Kc9jd0GUHVNBcwofnpF6UtcKRo680erzcpv1A3CMh8BVVRQELwlDQJtSs8oSUG7L1rtF3dmf5UWKGm8xtOXuE8BLkqAj6rWKzF/6JtEAlcGV/E/DnEcHOOZAj1QVGhvsYiIWwSSiqD6t56o2oFZTrQS3ThXui9xXwW8OhFMeuIq5jPFjSKRS9HVbA78MPqoHnApBPQJp/xmkVK/Bweydtk7f0vbXYC+xNXdRgWwUkprJ1Mal1mXFvQ+mtkGq2+HgGIXFMPQSvoSV5Xit2ulMc7B3wrfcT+IM9xoRlHbkKjpY6NBpkxHVKxdRdtbS1/iql7tPVprjXOCkvO16vyOOMONYhStJmtV2VI+AgrUUMBGJ+lDXK2QqQlxblGrRSWLxwi7zO1LX/3qG6s2mJayEdDN9ew+JvYhrlbNSnlVVckcrfANGtjdB+hE5/4I2CyRLqvphoBalr6v26l3nNWHuIoUKa0AnJoc/1NfUCo+v00xg4rdrNZ07a9H2RXpQ9xHAf9WIIR6C1B1jdJuKimgMnFToNxNhyqdfrrbqXc9qw9x1bBI7RxKFRWle/GEuilokVCLhZbyEIien9uHuKrGXnoSgJIVjggNrsqbzrgW3dtlgOICGmE01VRTxtDnI4x1pyH6EPdvmwRDxza443iKcFGbxeXqPncctqjT7gdcV5RF0zZG5WtUlmmQT7Y+xFVol8qj1CICUnnDY63rXNIqfy3XxFB26pNFBei/OZSCPsRVrV4FtNcmAlPB3IOBmgkQ5+FmAn6RWsUTaOFWObqDSR/iyqiaVzHVue4lhQSRxJjgmj5dYvhb4hh6kKldibLZBpW+xFXy8Ly2goM60HNwtVhUGdMxvD4rz1PVNi15EFAnvl1DLevBLehLXIUban+qdtHq+FFDLSQkAidFUYNErlSnRrEDetKqrWwS6Utc9QFqnZKUxLNuSnQjUsaGso9qk01S3e1rA2Zge/UtK9Im3bHoS1xtLF86MDA5hv/XQOBBFxgiO7ZSm9PIqjxcQODbgNrvxOhq3wrUvsRVX5o/tNJY18EXhgofg7WSiAjH6hOKEosIW+ehRNZNAW0zJpe+xJXBCppW7akxi4p4nVLBK3TNq/y1XT9ajMq2MBuDuDsCaic4Bbk8lIuN1lk8MmgmbmRAVxhOZVn1eZJFYhBXhmvfalZiMosjiZWqu+CZgEqhJiuC3cBH2bJag+N8SH8EVLxQnydZJBZxp1qEW9/3Ks72HkDVJ3LLL4F1chsxIf2x+NMasliKVwGunXi/GpFGBP4goKbdOURJBko2sKRBIBZ/WlsbU7Gyb97e2oJxnqCbmMqT6FU6ZdNurX5vOU5Ii/RKrXdUtDC5xCSujFffEy2RW+5AQHvBWpX+SII0yCtCYW7jnwYBFS+4NY2qO2uJTVwVR1+qJUMO30rUqS4DIrD6If37AAb+B6BeNpY0CKyZq+pIbOIKLnVCV0d0y3wEVLNLW2lfDNVE+kbgaDyllFnSILB2jqgpuTYEcUus/phmGvtr0aa+4qT10z6hcju16KW/ioVdKYhdscp6JVfLR0saBNQ8PGmM8sytIYirsY/v2lohDd7WYgSiIKA6X7qxJpehiCtHvgJsn9wjKzQC6RBQ28yb06m7Q9OQxNV+orZCcvUWyoGndU4LAbXhqTbJYKWp2gcoNa53WpeYvR0CAYWXZsmOG/KJOwNKja/VANtiBMaGQAr+LIlZKsVKTH/S2GbN/kwegVT8uQvQXRQfCagrfFvRXuXObU/y8UagUASUibVGLtvaEndWZUElO5Q8r0igpiInFTG0W9MTfJwRKBiBGwDVFs8ibYm7MGle+YhHA+9sablCIhUaaTECNSOgXsTqHpFF2hL3ucB5iyxVaVPl47bpDHAicEIWj63UCMRB4DvAtnGGaj9KW+KeFvrvLKXpvaEuU9PKiAcAFwBKjbIYgdoQUJLILrmMbktckfPgOcZ+FjgbUIe8eaLcUWXLqO+NxQjUhIDWa/bLZXBb4l4SWgc2sVcf76oIIWIq/HE50RP3WOAYQJEoFiNQAwL/DByay9C2xNX3rBpatxU1Q7osEFhlXX4Ssl80jkIj1bBKokZcG7Yd3McbgQwIvD40jcugun1an5pKqbmUxQhMHQH1Wj49Fwhtn7haeNo6l7HWawQKQuA5wLtz2dOWuAq8eEguY63XCBSEwN6A1nyySFviuqZRlmmy0gIR0LpMtn7EbYmrrR51J7MYgakjkC2JXsC3Ja6KfR849Rmz/0agA3eigtaWuCp4rsLnFiMwZQTUgT5rr6y2xFWgRLYl8ClfKfa9KAT0yfjYnBa1Je4TgI/nNNi6jUABCCikV4k12aQtcVW7V1FPFiMwZQT05vnGnAC0Ja5sVQyy6slajMBUEdgfuDin812IK4OfmNNo6zYCmRFQ2O/3ctrQhbhHAWfkNNq6jUBmBFYFbstpQxfiqo2m2mlajMAUEbgG2Cq3412IK5tVtmOWipfbB+s3AikRUGO17EFIXYmrInFvTomWdRmBQhB4ZQkN7boSV5UqflMIkDbDCKREIPuKspztSlyd+y5AOYkWIzAlBDYGrsvtcB/ibgaotqzFCEwFATUbX7cEZ/sQV/afAxxegiO2wQgkQEDhvkXEMPQl7gaAMiXUbtBiBMaOQBELU32/cWeTpDQ/pftZjMDYEdgTuLQEJ/s+cWc+fBnYoQSHbIMRGBCBbB3oF/sUi7haafsuoG5+FiMwRgS+BWxXimOxiCt/9g1tNEvxzXYYgZgIKOBI3TaKkJjElUOvBV5ehGc2wgjEReBJwEfjDtl9tNjElSVn5a4O0B0On2kElkVgbeCmUvAZgrjy7UzgyFKctB1GoCcCRX3fypehiKux9cqsV2eLEagdgZOBV5XkxJDElZ+7AkqDKiJMrCTgbUtVCDwSUKfKYmRo4srR9UPn+T2K8dqGGIHmCBQTn7zQ5BTEnelTE2BVxnPz6uYXjY/Mj4A68hWXBZeSuJoCNa3WqvN++efDFhiBRggoqaC4WuKpiTtDavtQRcANxBpdOz4oEwK3AvfIpHtFtbmIOzNqF+DVwO4lgmObJo/Ae4BDSkQhN3FnmGwR8nqf5RXoEi+TydqkMN5PlOh9KcRdiM1BIe55N0D5vhYjkAOBW4A1cyhuorNE4i60W60MtRcsEu8MbNTEKR9jBCIgcC5wRIRxBhmidOIudlo9i3YMub9a4HoYcPdBkPGgU0dgJ0B55kVKbcRdCKIIrJhokddiBGIioCKIWncpVmojrkInDwAOBrQibTECQyBQTG2p5ZzLQdxtgFeE0q7XAj8F/rKMgSKqgjY2D9+6bnsyxGXqMRcjUETt5JWmJQdxtVJ3s68VI1AoAh8Jb3WFmne7WTmIK71fBZRxYTECpSGgXYwvlGbUYntyEfc44LTSwbF9k0PgKkCfcsVLLuK6x27xl8YkDXw2cH4NnucirrD5YgiqqAEn2zh+BIrMu10O9pzEPQxQdIrFCJSAwLEhX7wEW+bakJO4qwLXA2vNtdIHGIFhEVCv5/sBvxtWTbzRcxJXXiilr6giXPGg9UgVIXAScEJF9mbbDpphtE4IwHC8cU1Xzbhs/UNIXvl1TW7lfuIKK4WX6Y5nMQI5ENAbn8qvViUlEFe9dRXUvV5VyNnYMSBwI7AZ8PvanCmBuMJMxeOK6ctS2yTa3s4IPA84p/PZGU8shbiC4EJA1S8sRiAFAlcDW6dQNISOkoir5IMrXa5miGn2mEsgsBfwmVqRKYm4wnDbUHVAe7wWIzAUAh+rvbZ3acTVRKkA9cVDzZjHNQJh++dnNSNRInGF50uAU2sG1rYXi4A6SKqQQ9VSKnEF6hnAUVWja+NLQ0Dbjg8CbivNsLb2lExc+aKGSyqSbjECMRB4BPC1GAPlHqN04gqfC4Cn5wbK+qtH4A3Ai6v3IjhQA3Fl6vGhSdhYcLcfaREovtxqWzhqIa78UnSVgjSckNB2ln383wHfHhMMNRFXuD8YuAjYakyTYF8GRaCqBPmmSNRG3Jlf6mBwZFMnfdxkEbgM2GOM3tdKXM2FmmLr1Vn9hCxGYDECqiGlWGT9HZ3UTFxNhrqFK59Xr0MWI7AQgSrqI3edstqJO/Nb9YJOB57aFQifNyoEqkyObzMDYyHuzGd17jsR2KcNCD52VAhcCuw5Ko+WcGZsxJ25+ADgaOCZ3j4a+yV8J/9+HjoRqJv8qGWsxJ1Nmkq/Hgqo0oE6/lnGi4Aaye0ccrrH62XwbOzEXTiBegrvG36PGv3MTstBVWrcbSxxyE2mbkrEXYjHPYH9Q8/dHRzQ0eRSKfqYRwOXF21hZOOmStzFMIrIOwHbAzuGFqCrR8baww2DgAovfHyYocsd1cRdem5eP6ZMknIvv96WPQN4b+9RKhzAxL3rpGkrodoiYhVeg11N/kfgrK4n136eiXvnGdwF+DSgIu2WchHQXr36Tk1WTNw7pl6rkiLtKpO9GupwXBFyx9Vh6nBWmri3Y/sC4O3DweyRIyGguPTXRBqr6mGmTlzt7X4QeEjVszgN4xUJp3ROC2Rvs5lzEp4citF52yfnLDTTfThwXrNDp3HUFJ+42qt9HbD7NKa4ai/VRU832Euq9mIA46dEXNWs0uuWFqEs5SPw38DjphJ73HY6xk7c+wDPDokGm7QFx8dnQ+ArIaa8qi7xKdEaK3EVUSPC+nU45dUUR5eCKhRcYVkBgTERVxUglTjwfLfqrPaa1832/GqtT2h4zcRVfWUVjHtseK3yq3DCCyeyquvDTffrkccd7XC1EVcFwPT6qzQuhSda6kfgU8AhY63GONT0lEpcVW/cBrg/oCAJJb6ruoFlPAj8ETgGOHs8LqXzpATibgpsBqiTmoq96e9900FgTRkQUMe8gwD19LF0QCAFcbcIRBRBNw6/jQJZ/V3aYdIqP0VNpdVc2tIDgT7EVdWIDcMKruoaa89UPz0t1wdE1HV72OZTx4XAN8K37PfG5VYeb1Yirkj4ImANQPG8+qtvzxlZ3TUvz5zVqPVlwKk1Gl6qzfOeuNoXVVf4NUt1wHYVjcDnQjDF1UVbWaFx84grl9YJmRkiscUINEHgupDsrpRJywAINCHuTO2zgLeG1+YBTPGQI0BA9Y1PcbL78DPZhriyRqvCenV2DPDwc1OThtuAc8Nq8Y01GV6rrW2JO/NTkS5vAu5Vq+O2OxoCCqA4GVDfHksiBLoSV+ZphfmlwAtdYC3RbJWl5m1hpVhxxpbECPQh7szU9YCTAJUXsYwbAb0SK+1OBeNvGLerZXsXg7gzDxVwoYgYhbJZxoXAb0MVzDcAN43LtTq9iUncGQJKDlDB6qfUCYmtXoDAr4Azwm6CyGspBIEhiDtzTYkD+gY+rBBfbUZzBBT8r6erM3eaY5b0yCGJO3NE8coKnVTRcYVNWspF4DLgXcD7yzXRlgmBFMSdIa14Z3WG1yq04p0tZSDwTeB9oeud92DLmJO5VqQk7kJjjgCODMnyc430AdER+CHwAeAC4PvRR/eAgyOQi7gzx5Q4r1BKrUQ7mGPY6Vb88EWBsEqxs1SMQG7iLoTuwJCv+fiK8SzN9F8EsoqwXyrNONvTHYGSiDvzQnm+qmC/L7APcO/u7k3yTO2zfjg8WZVWZxkhAiUSdzHMOwQC7w1sN8I5iOGSvlkvBy4GPhljQI9RNgI1EHchgmsDe4Un8p6Awi2nKD8APr/g5wD/iV0FtRF38fQ8FNgJ0FNZP6UdjlFmT9QZWU3UMc5yC59qJ+5iV/U9LCLvCDw81GXeoAUeuQ/Vk/Qq4BpA5V709wrg1tyGWX9ZCIyNuEuhuyqwJaAysZuHvwrHVDVKkVrVKlOJYn/VPlI/pcNdG/ZRRdIrUxlhPfUjMAXizpulVUJZWZFYP0V1rQWsFvKM/yb81XGz318Bfwo/pbrN/lt/Z/++ZRFJXfx73kz4/zdGwMRtDJUPNALlIGDiljMXtsQINEbAxG0MlQ80AuUgYOKWMxe2xAg0RsDEbQyVDzQC5SBg4pYzF7bECDRG4P8A3SKu5/rwGYoAAAAASUVORK5CYII=';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
